Since interagency cooperation isn’t succeeding organically, it’s time for top-down initiatives led by a Health and Human ...
Researchers worry that Medicaid home care eligibility decisions are often made without public scrutiny and based less on ...
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...
The Food and Drug Administration on Thursday delivered a split decision on a blood cancer drug from GSK, approving its use in ...
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
The Food and Drug Administration yesterday delivered a split decision on GSK’s blood cancer drug Blenrep, approving its use ...
Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.
Submit a response to a recent First Opinion essay below. Selected submissions will appear in our weekly letter to the editor roundup, published every Saturday.
More than 420 anti-science bills attacking longstanding public health protections have been introduced in statehouses across ...
New analysis finds the median net price for 154 newly launched drugs, when adjusted for inflation and manufacturer discounts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback